Literature DB >> 7946765

Optimising heart failure pharmacotherapy: the ideal combination.

J G Cleland1, D P Dutka.   

Abstract

Good management of all patients with heart failure is complex. Fortunately most patients fall into only one or two categories, making management less daunting. Most patients with heart failure need treatment with loop diuretics and ACE inhibitors and for many these drugs, possibly combined with antithrombotic measures, are all that is needed for optimal treatment, but optimal treatment can only follow adequate diagnosis. This needs a partnership between the specialist and the family doctor, with ease of access to non-invasive investigations such as echocardiography.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946765      PMCID: PMC1025581          DOI: 10.1136/hrt.72.2_suppl.s73

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  35 in total

1.  The effect of warfarin on mortality and reinfarction after myocardial infarction.

Authors:  P Smith; H Arnesen; I Holme
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

2.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

3.  Evaluation of the safety of enalapril in the treatment of heart failure in the very old.

Authors:  C J O'Neill; S G Bowes; C M Sullens; J P Royston; W B Hunt; M J Denham; R J Dobbs; S M Dobbs
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Lisinopril versus placebo in older congestive heart failure patients.

Authors:  G R Lewis
Journal:  Am J Med       Date:  1988-09-23       Impact factor: 4.965

5.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

6.  Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.

Authors:  F Waagstein; K Caidahl; I Wallentin; C H Bergh; A Hjalmarson
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

7.  Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.

Authors:  J G Cleland; H J Dargie; S G Ball; G Gillen; G P Hodsman; J J Morton; B W East; I Robertson; I Ford; J I Robertson
Journal:  Br Heart J       Date:  1985-09

8.  A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.

Authors:  R DiBianco; R Shabetai; W Kostuk; J Moran; R C Schlant; R Wright
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

9.  Metolazone in treatment of severe refractory congestive cardiac failure.

Authors:  A Kiyingi; M J Field; C C Pawsey; J Yiannikas; J R Lawrence; W J Arter
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

10.  Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure.

Authors:  R J Cody; S Torre; M Clark; K Pondolfino
Journal:  Arch Intern Med       Date:  1989-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.